Clinical Trial

Integrating Whole Genome Sequencing and Digital Twins Into the Management of Hypercholesterolemia in Emiratis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2025 (before its estimated December 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This pilot study investigates integrating whole genome sequencing and digital twin technology for managing hypercholesterolemia in Abu Dhabi clinics. It aims to establish protocols for larger future studies and incorporate genomic insights into routine medical care.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-30; most recent amendment 2025-03-24.
Status change: Not Yet Recruiting → Recruiting 2024-08-05
Trial Details
NCT Number NCT06535542
Lead Sponsor Abu Dhabi Health Services Company
Collaborators: Predictiv Care, Inc.
Conditions Hypercholesterolemia, Autosomal Dominant, Hypercholesterolemia, Autosomal Recessive, Familial Combined Hypercholesterolemia
Enrollment 40 participants
Start Date 2024-07-29
Primary Completion 2025-12-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-25